MedPath

Auditory and visual stimuli test proposal for tinnitus patients evaluatio

Not yet recruiting
Conditions
adult
tinnitus
attention
cognition
H02.010.150
Registration Number
RBR-7gw2794
Lead Sponsor
niversidade Federal de São Paulo (UNIFESP-EPM)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Not yet recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

As inclusion criteria, will be selected, individuals aged between 18 and 59 years old, with tinnitus and hearing thresholds within normal limits for pure tone audiometry or hearing loss at high frequencies (above 3kHz). Such subjects must have performed acuphenometry in a previous audiological evaluation and must present constant subjective tinnitus, of the whistle or wheezing type, uni or bilateral. The Control Group will comprise individuals without tinnitus, aged between 18 and 59 years, pure tone audiometry within normal limits or with hearing loss at high frequencies (from 3kHz), with no history of neurological and/or psychiatric alterations.

Exclusion Criteria

Individuals with pulsatile tinnitus, psychiatric or neurological diseases diagnosed up to the time of test execution will be excluded from the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
It is expected to find a statistically significant difference between the performance of subjects with and without tinnitus, through the assessment method with the proposed visual auditory Stroop test. In all conclusions obtained through inferential analysis, the level of alpha significance equal to 5% will be used. A worse performance of subjects with tinnitus is expected, confirming the hypothesis of failures in attention and cognitive control mechanisms in tinnitus patients.
Secondary Outcome Measures
NameTimeMethod
It's expected to find worse performance in the Study Group for stimulus that correspond to the frequency of tinnitus perception. In all conclusions obtained through inferential analysis, the level of alpha significance equal to 5% will be used.
© Copyright 2025. All Rights Reserved by MedPath